经过大剂量急性甲福明过量服用后,持续的双心脏功能障碍
Danae Massengill1, Maria Fouad Abou Nader2, Ryan Good2
1Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, Colorado.
Pediatrics
|May 14, 2025
概括
急性甲福明毒性会导致严重的心脏功能障碍,即使在纠正代谢性酸性化症后. 这一案例凸显了大量摄入甲胺时可逆心脏毒性的潜力.
科学领域:
- 毒理学 毒理学 毒理学
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 代谢性酸性和高乳糖血是急性甲福林毒性的已知的并发症.
- 急性心脏并发症,特别是心脏毒性,在甲福林过量服用的情况下不经常被描述.
研究的目的:
- 报告严重的双心室心脏功能障碍的病例,该病例是在大量的急性甲福林摄入后发生的.
- 为了强调急性,可逆心脏毒性的潜力,作为显著的甲胺过量剂量的并发症.
主要方法:
- 一个13岁的女性的病例报告,她摄入了150克的甲福林.
- 使用了临床监测,实验室分析,连续脏替代疗法和心声回声学.
- 治疗包括对代谢障碍,血管压缩剂和异型药物的纠正.
主要成果:
- 患者患有严重的代谢性酸性化症,高乳糖血症和急性损伤.
- 尽管酸症迅速纠正,但她经历了双心室心脏功能障碍,需要密集支持.
- 治疗1周后心脏功能正常化,血管压缩剂和异能药物需求得到解决.
结论:
- 急性摄入甲福明可以导致严重的,可逆性心脏毒性,独立于代谢性酸症.
- 临床医生应考虑在大量摄入甲福明的患者心脏毒性,即使及时纠正酸干扰.
- 这一案例强调了对末端器官损伤进行全面监测的重要性.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
142
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
142
Heart Failure Drugs: Inotropic Agents
440
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
440
Hypoglycemia and Glucagon
142
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
142
Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications
487
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
487
Insulin: Dosing Regimen and Adverse Effects
129
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
129


